NCT05565313View on ClinicalTrials.gov

Predicting Radiological Extranodal Extension in Oropharyngeal Carcinoma Patients Using AI

Active, not recruitingOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

March 22, 2022

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2026

Conditions
Head and Neck Carcinoma
Trial Locations (3)

02115

Harvard Medical School and clinical faculty at Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston

M5G 2M9

Princess Margaret Cancer Centre, Toronto

6229 ET

Maastro, Maastricht

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Princess Margaret Hospital, Canada

OTHER

lead

Maastricht Radiation Oncology

OTHER